Related Experiment Videos
Graft atherosclerosis: effects of cellular rejection and human lymphocyte antigen
1Department of Cardiothoracic Surgery, Presbyterian Hospital of Pittsburgh, University of Pittsburgh School of Medicine, PA 15216.
Insights
Cellular rejection significantly impacts graft atherosclerosis after heart transplantation, potentially limiting long-term survival. HLA compatibility and antibodies did not show a significant association with this complication.
Area of Science:
- Cardiology
- Transplantation Immunology
- Pathology
Background:
- Graft atherosclerosis is a major complication following heart transplantation, significantly impacting patient survival.
- Understanding the factors contributing to graft atherosclerosis is crucial for improving long-term outcomes in heart transplant recipients.
Purpose of the Study:
- To investigate the association between graft atherosclerosis and key immunological factors including cellular rejection, HLA compatibility, and antilymphocyte antibodies.
- To determine the primary drivers of graft vessel disease in heart transplant recipients.
Main Methods:
- Cineangiograms from 306 heart transplant recipients were analyzed.
- Life table and logistic regression analyses were employed to assess associations.
- Coronary vessel narrowing was quantified by planimetry in 146 explanted allografts.
- Linear regression was used to evaluate the relationship between cellular rejection and coronary narrowing.
Main Results:
- Cellular rejection was identified as the sole significant factor associated with the development of angiogram-evident graft vessel disease.
- A positive association was found between a history of cellular rejection and coronary vessel narrowing.
- Panel reactive antibody levels and HLA mismatch did not demonstrate a significant impact on graft atherosclerosis.
Conclusions:
- Cellular rejection is a critical determinant of graft atherosclerosis following heart transplantation.
- The findings suggest a cautious approach is needed when directly linking graft atherosclerosis solely to the rejection event, despite the observed association.
- Further research may be warranted to elucidate the complex interplay of factors influencing graft atherosclerosis.
Abstract:
Graft atherosclerosis after heart transplantation is a problem that may limit long-term survival. The objective of this study was to establish whether an association exists between graft atherosclerosis, cellular rejection, HLA compatibility, or antilymphocyte antibodies in recipient serum. Results of cineangiograms from 306 recipients were available. Life table and logistic regression analysis identified only a significant effect of cellular rejection on development of angiogram-evident graft vessel disease. A total of 146 allografts obtained at another transplantation or autopsy were also available. Coronary vessel narrowing was measured by planimetry. Linear regression with coronary narrowing as dependent variable established a positive association with history of cellular rejection. No effect was documented for panel reactive antibody level obtained before or after transplantation. We also did not show an impact of HLA mismatch on this process. The lack of HLA antigen effect prompts us to be cautious about linking graft atherosclerosis directly to the rejection event.